PATENT CLAIM ANALYSIS

Application Number: 16189019
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-10
Patent Classification: ["514", "372000"]

Abstract:
The present application relates to topical formulations comprising Compound-I or its free base, and a second active agent selected from nicotinic acid, nicotinamide, and vitamin K, and a combination thereof, for treating ocular neovascularization. The present application also relates to pharmaceutical compositions comprising particles of Compound-I or its free base, and suspension formulations comprising the particle compositions of Compound-I or its free base.

Claim (Index 11):
The formulation of  claim 3 , wherein the second active agent is present in an amount of about 1 \u03bcM, about 2 \u03bcM, about 3 \u03bcM, about 4 \u03bcM, or about 5 \u03bcM.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.73171
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15718176', '14857758', '15080893', '16042003', '14775357']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8052400898971089
- 35 USC 102 Novelty (BERT): 0.609375135909506
- Combined Prediction Score: 0.7856535944983486
- Mean Citation Score: 451.279804
- Max Citation Score: 566.8214
- Similarity Product: 484.1219825435281

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test